Allan Barbee
Finance Director, Core Business Services, Americas Migration
GLAXOSMITHKLINE
Al Barbee is the Director of CBS Finance Transformation – Americas for GlaxoSmithKline, a global pharmaceutical and consumer healthcare company. He is responsible for the implementation of GSK’s Finance Target Operating Model across North, Central and South America for the following financial processes: Procure to Pay (including Travel & Expense), Record to Report, Order to Cash and Tax/Statutory Accounts. During his 15 year tenure in Shared Financial Services, Al has led multiple process improvement initiatives increasing the efficiency and effectiveness of the core financial processes.
Allan will be one of the distinguished speakers at the 6th Semi-Annual Life Science Financial Forum.
Why are the 6th & 7th Semi-Annual Life Science Financial Forums important to financial executives?
For the opportunity to see what other finance colleagues in the industry are addressing as top priorities.
What initiatives are on the horizon at your organization for the financial department in 2015-2016?
- Implementing Global SAP ERP system/processes
- Integration of acquired businesses into our Finance Target Operating Model
- Improving processes for greater efficiencies
How has your organization increased operational effectiveness within the finance department?
- Leveraging new operating model
- Implementing ADP culture across the organization.
How has the increase in consolidation/M&A affected the life science industry?
Cost saving initiatives are based on process efficiencies and not purely synergy savings.
